MTOR and hepatocellular carcinoma: HCC data was assessed using survival analysis to measure PTEN, PI3K/AKT/mTOR pathway, β-catenin/BCL2, and β-catenin/HSP90 effect on prognosis of hepatocellular carcinoma patients using Kaplan–Meier (KM) plots.